Seattle company gets FDA approval for nasal spray to treat migraines, promising ‘efficacy on demand’

The Seattle biopharmaceutical Impel NeuroPharma gained U.S. Food and Drug Administration approval for a nasal spray that treats migraines.

source https://www.seattletimes.com/business/seattle-company-gets-fda-approval-for-nasal-spray-to-treat-migraines-promising-efficacy-on-demand/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology